Med Clin (Barc). 1992 Jan 18;98(2):41-4. Unique Identifier : AIDSLINE
BACKGROUND: To evaluate the prevalence of neurological and cognitive
disorders in patients with the human immunodeficiency virus type 1
(HIV-1). METHODS: A transversal prospective study was carried out in 56
patients with HIV-1 and in 18 seronegative subjects by a protocolized
neurological and cognitive examination. RESULTS: Twenty-seven patients
were intravenous drug users (IVDU) and 29 were male homosexuals.
Nineteen were in stage III of HIV-1 infection and 37 were in the initial
phases of stage IV. No significant differences were found in the
cognitive performance of patients in stage III when the control group
was compared with seropositive patients. Significant differences were
observed in stage IV in the Rey figure complex tests the B trace test
and the number key. Three stage IV patients presented dementia criteria.
No significant differences were seen in test performance upon comparing
the ex-iVDU seropositive subgroup with the male homosexuals nor in the
stage III or stage IV groups. CONCLUSIONS: Cognitive performance of
stage III patients did not significantly differ from that of the
seronegative control group; a global diminution in cognitive performance
was observed in the stage IV group and there were no differences in the
cognitive state between the two risk groups analyzed.
Acquired Immunodeficiency Syndrome/CLASSIFICATION/*COMPLICATIONS Adult
Cognition Disorders/DIAGNOSIS/*ETIOLOGY Comparative Study English
Abstract Female Human HIV Seropositivity *HIV-1 Male Nervous
System Diseases/DIAGNOSIS/*ETIOLOGY Neurologic Examination
Neuropsychological Tests Support, Non-U.S. Gov't JOURNAL ARTICLE